ABO subgroup incompatibility with severe hemolysis after consecutive allogeneic stem cell transplantations
© 2021 The Authors. eJHaem published by British Society for Haematology and John Wiley & Sons Ltd..
Allogeneic hematopoietic stem cell transplantations (HSCTs) represent a curative strategy for treating hematologic malignancies yet bear dangerous and frequently life-threatening complications including the development of graft-versus-host disease. Here, we present a case of a patient that suffered from relapsed/refractory multiple myeloma, a hematologic neoplasm characterized by clonal proliferation of malignant plasma cells in the bone marrow. During the course of his disease, the patient underwent consecutive allogeneic HSCTs, during which he developed a clinical meaningful and hitherto unreported ABO subgroup incompatibility, leading to persistent hemolysis. Testing for ABO subgroups during donor selection, especially after consecutive allogeneic HSCTs, may therefore aid to prevent these complications.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:2 |
---|---|
Enthalten in: |
EJHaem - 2(2021), 2 vom: 16. Mai, Seite 280-284 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Hecker, Judith S [VerfasserIn] |
---|
Links: |
---|
Themen: |
A1/A2 subtyping of blood group A |
---|
Anmerkungen: |
Date Revised 19.07.2022 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.1002/jha2.190 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM343654997 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM343654997 | ||
003 | DE-627 | ||
005 | 20231226020945.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1002/jha2.190 |2 doi | |
028 | 5 | 2 | |a pubmed24n1145.xml |
035 | |a (DE-627)NLM343654997 | ||
035 | |a (NLM)35845280 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Hecker, Judith S |e verfasserin |4 aut | |
245 | 1 | 0 | |a ABO subgroup incompatibility with severe hemolysis after consecutive allogeneic stem cell transplantations |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 19.07.2022 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a © 2021 The Authors. eJHaem published by British Society for Haematology and John Wiley & Sons Ltd. | ||
520 | |a Allogeneic hematopoietic stem cell transplantations (HSCTs) represent a curative strategy for treating hematologic malignancies yet bear dangerous and frequently life-threatening complications including the development of graft-versus-host disease. Here, we present a case of a patient that suffered from relapsed/refractory multiple myeloma, a hematologic neoplasm characterized by clonal proliferation of malignant plasma cells in the bone marrow. During the course of his disease, the patient underwent consecutive allogeneic HSCTs, during which he developed a clinical meaningful and hitherto unreported ABO subgroup incompatibility, leading to persistent hemolysis. Testing for ABO subgroups during donor selection, especially after consecutive allogeneic HSCTs, may therefore aid to prevent these complications | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a A1/A2 subtyping of blood group A | |
650 | 4 | |a ABO incompatibility | |
650 | 4 | |a allogeneic hematopoietic stem cell transplantation | |
650 | 4 | |a hemolysis | |
700 | 1 | |a Wahida, Adam |e verfasserin |4 aut | |
700 | 1 | |a Hameister, Erik |e verfasserin |4 aut | |
700 | 1 | |a Filo, Aneta |e verfasserin |4 aut | |
700 | 1 | |a Ruland, Jürgen |e verfasserin |4 aut | |
700 | 1 | |a Bassermann, Florian |e verfasserin |4 aut | |
700 | 1 | |a Hildebrandt, Martin |e verfasserin |4 aut | |
700 | 1 | |a Verbeek, Mareike |e verfasserin |4 aut | |
700 | 1 | |a Poeck, Hendrik |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t EJHaem |d 2020 |g 2(2021), 2 vom: 16. Mai, Seite 280-284 |w (DE-627)NLM314118454 |x 2688-6146 |7 nnns |
773 | 1 | 8 | |g volume:2 |g year:2021 |g number:2 |g day:16 |g month:05 |g pages:280-284 |
856 | 4 | 0 | |u http://dx.doi.org/10.1002/jha2.190 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 2 |j 2021 |e 2 |b 16 |c 05 |h 280-284 |